MannKind Corp MNKD:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 8:32 AM EST
3.69quote price arrow up+0.07 (+1.93%)
Volume
17,755
Close
3.62quote price arrow down-0.16 (-4.23%)
Volume
8,967,346
52 week range
0.80 - 6.25

...

Loading . . .

KEY STATS

  • Open3.80
  • Day High3.85
  • Day Low3.61
  • Prev Close3.62
  • 52 Week High6.25
  • 52 Week High Date02/24/21
  • 52 Week Low0.80
  • 52 Week Low Date03/16/20
  • Market Cap894.72M
  • Shares Out247.16M
  • 10 Day Average Volume10.16M
  • Dividend-
  • Dividend Yield-
  • Beta2.03
  • 1 Year % Change186.17

RATIOS/PROFITABILITY

  • EPS (TTM)-0.26
  • P/E (TTM)-13.95
  • Fwd P/E (NTM)-25.49
  • EBITDA (MRQ)-35.369M
  • ROE (MRQ)-
  • Revenue (MRQ)65.14M
  • Gross Margin (MRQ)62.94%
  • Net Margin (MRQ)-87.87%
  • Debt To Equity (MRQ)-67.75%

EVENTS

  • Earnings Date05/08/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest MannKind Corp News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
MannKind Corporation is a biopharmaceutical company. The Company is focused on the development and commercialization of inhaled therapeutic products for diabetes and orphan lung diseases, such as pulmonary arterial hypertension. The Company's product candidate is Afrezza (insulin human) Inhalation Powder, which is an inhaled insulin used to control high blood sugar in adults with type I and type II diabetes and also to improve glycemic control. AFREZZA consists of a dry...
James Shannon M.D.
Chairman
Michael Castagna Pharm.D.
Chief Executive Officer
Steven Binder CPA
Chief Financial Officer
Joseph Kocinsky
Chief Technology Officer
David Thomson Ph.D., J.D.
Executive Vice President
Rosabel Alinaya CPA
Vice President
Address
30930 Russell Ranch Rd Ste 300
Westlake Village, CA
91362-7379
United States